| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota 55905
Address all correspondence and requests for reprints to: K. S. Nair, Endocrine Research Unit, Mayo Clinic, 200 First Street SW, Joseph 5-194, Rochester, Minnesota 55905. E-mail: nair.sree{at}mayo.edu.
Context: Abnormal homocysteine metabolism may contribute to increased cardiovascular death in type 1 diabetes (T1DM). Amino acid metabolism is altered in T1DM. In vitro, insulin reduces hepatic catabolism of homocysteine by inhibiting liver transsulfuration. It remains to be determined whether methionine-homocysteine metabolism is altered in T1DM.
Objective: We sought to determine whether insulin deficiency during insulin deprivation or high plasma insulin concentration after insulin treatment alters homocysteine metabolism in T1DM.
Design: This was an acute interventional study with paired and comparative controls.
Setting: The study was conducted at a general clinical research center.
Patients and Intervention: We used stable isotope tracers to measure methionine-homocysteine kinetics in six patients with T1DM during insulin deprivation (I–) and also during insulin treatment (I+) and compared them with nondiabetic controls (n = 6).
Main Outcome Measures: Homocysteine kinetics (transmethylation, transsulfuration, and remethylation) were from plasma isotopic enrichment of methionine and homocysteine and 13CO2.
Results: T1DM (I–) had lower rates of homocysteine-methionine remethylation (P < 0.05 vs. control and I+). In contrast, transsulfuration rates were higher in I– than controls and I+ (P < 0.05). Insulin treatment normalized transsulfuration and remethylation (P < 0.05 vs. I– and P > 0.8 vs. control). Plasma homocysteine concentrations were lower in T1DM (P < 0.05 vs. control during both I– and I+), which may be explained by increased homocysteine transsulfuration. Thus, significant alterations of methionine-homocysteine metabolism occur during insulin deprivation in humans with T1DM.
Conclusions: Insulin plays a key role in the regulation of methionine-homocysteine metabolism in humans, and altered homocysteine may occur during insulin deficiency in type 1 diabetic patients.
This article has been cited by other articles:
 |
|
 |
|
  M Jensen-Waern, M Andersson, R Kruse, B Nilsson, R Larsson, O Korsgren, and B Essen-Gustavsson Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism Lab Anim, July 1, 2009; 43(3): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Wilson, J. J. G. C. van den Borne, A. G. Calder, N. O'Kennedy, G. Holtrop, W. D. Rees, and G. E. Lobley Tissue methionine cycle activity and homocysteine metabolism in female rats: impact of dietary methionine and folate plus choline Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E702 - E713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-P. I. Chiang, Y.-C. Wang, W.-W. Chen, and F.-Y. Tang Effects of Insulin and Glucose on Cellular Metabolic Fluxes in Homocysteine Transsulfuration, Remethylation, S-Adenosylmethionine Synthesis, and Global Deoxyribonucleic Acid Methylation J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 1017 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.E. Lazzerini, P.L. Capecchi, E. Selvi, S. Lorenzini, S. Bisogno, M. Galeazzi, and F. Laghi Pasini Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases? Lupus, November 1, 2007; 16(11): 852 - 862. [Abstract] [PDF]
|
|
|
|
 |
|
 K. T. Williams and K. L. Schalinske New Insights into the Regulation of Methyl Group and Homocysteine Metabolism J. Nutr., February 1, 2007; 137(2): 311 - 314. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
